Home > Balance Sheet > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹4.47 Cr₹3.48 Cr₹6.71 Cr₹16 Cr₹1.69 Cr

What is the latest Capital Work in Progress ratio of LINCOLN PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of LINCOLN PHARMACEUTICALS is ₹4.47 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹4.47 Cr
Mar2024₹3.48 Cr
Mar2023₹6.71 Cr
Mar2022₹16 Cr
Mar2021₹1.69 Cr

How is Capital Work in Progress of LINCOLN PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹4.47 Cr
28.34
Mar2024 ₹3.48 Cr
-48.12
Mar2023 ₹6.71 Cr
-58.18
Mar2022 ₹16 Cr
852.19
Mar2021 ₹1.69 Cr -

Compare Capital Work in Progress of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,147.3 Cr -2.1% -7.2% 11.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,495.0 Cr -5.7% -3.3% -2.1% Stock Analytics
DIVIS LABORATORIES ₹154,244.0 Cr -3.1% -9.3% 0% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,634.0 Cr -6.1% -8.3% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,594.0 Cr -5.1% -6% 4.8% Stock Analytics
CIPLA ₹97,022.8 Cr -3.3% -11.2% -19.5% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-2.1%

-7.2%

11.5%

SENSEX

-1.6%

-8.8%

-4.1%


You may also like the below Video Courses